A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 328 participants.
Also called NCT01370603
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 328 participants
- Sponsor
- Registry
-
NCT01370603
-
- Other papers using this trial's data
- Fixed-dose combination ezetimibe+atorvastatin lowers LDL-C equivalent to co-administered components in randomized trials: use of a dose-response model
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01370603. Randomized; double masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2013-07-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Ezetimibe
- Intervention (Drug)
- Ezetimibe/atorvastatin
- Intervention (Drug)
- Placebo to atorvastatin
- Intervention (Drug)
- Placebo to ezetimibe
- Intervention (Drug)
- Placebo to ezetimibe/atorvastatin
- Lead sponsor
- Organon and Co
Record details
- Record id
cardio:ct-nct01370603- Content hash
3799dc0b3cd02a08ac3ad3bd814194dfea5d93242b9fecdd34aeba308f3816d6